Weight-Loss Drugmaker Lilly Surpasses Tesla in Value After $85 Billion Wipeout
[ad_1] (Bloomberg) — Weight-loss drug innovators have unseated electric carmakers as some of 2024’s must-own stocks. Tesla Inc.’s $85 billion wipeout, spurred by investor anxiety about slowing growth, saw Eli…